| Literature DB >> 35855194 |
S P Somashekhar1, Richa Jaiswal1, Rohit Kumar1, B C Ashok2, Susmita Rakshit3, Amit Rauthan4, H K Karthik1, Archa Prasad1, Herra Islam1, Aaron Fernandes1, Elroy Saldahana1, K R Ashwin1.
Abstract
Mucormycosis is a rare, but potentially fatal, fungal infection which is caused by mucormyctes. These forms of fungi are typically known to infect immuno-compromised individuals but are rare in immunocompetent individuals. Herein, we report the case of a 52 year-old female who was diagnosed with right breast carcinoma in Manipal Hospital, a tertiary cancer care center. The patient was a known diabetic and hypertensive and who had recently recovered from coronavirus disease-2019 (COVID-19) pneumonia. In the due course of management, she developed mucormycosis infection at the operative site in her right breast where she had a radiation therapy-induced wound. This patient was successfully treated with an aggressive regimen of early surgical debridement along with administration of systemic amphotericin B. ©Copyright 2022 by the the Turkish Federation of Breast Diseases Societies / European Journal of Breast Health published by Galenos Publishing House.Entities:
Keywords: Axillary dissection; COVID-19; breast carcinoma; chemotherapy; mucormycosis; neoadjuvant chemotherapy
Year: 2022 PMID: 35855194 PMCID: PMC9255654 DOI: 10.4274/ejbh.galenos.2022.2022-2-4
Source DB: PubMed Journal: Eur J Breast Health